235 related articles for article (PubMed ID: 20132919)
41. Efficacy of live attenuated vaccines against 2009 pandemic H1N1 influenza in ferrets.
Stittelaar KJ; Veldhuis Kroeze EJ; Rudenko L; Dhere R; Thirapakpoomanunt S; Kieny MP; Osterhaus AD
Vaccine; 2011 Nov; 29(49):9265-70. PubMed ID: 21945964
[TBL] [Abstract][Full Text] [Related]
42. Vaccines That Reduce Viral Shedding Do Not Prevent Transmission of H1N1 Pandemic 2009 Swine Influenza A Virus Infection to Unvaccinated Pigs.
Everett HE; van Diemen PM; Aramouni M; Ramsay A; Coward VJ; Pavot V; Canini L; Holzer B; Morgan S; ; Woolhouse MEJ; Tchilian E; Brookes SM; Brown IH; Charleston B; Gilbert S
J Virol; 2021 Jan; 95(4):. PubMed ID: 33268518
[TBL] [Abstract][Full Text] [Related]
43. Efficacy of swine influenza A virus vaccines against an H3N2 virus variant.
Lee JH; Gramer MR; Joo HS
Can J Vet Res; 2007 Jul; 71(3):207-12. PubMed ID: 17695596
[TBL] [Abstract][Full Text] [Related]
44. DNA vaccination elicits protective immune responses against pandemic and classic swine influenza viruses in pigs.
Gorres JP; Lager KM; Kong WP; Royals M; Todd JP; Vincent AL; Wei CJ; Loving CL; Zanella EL; Janke B; Kehrli ME; Nabel GJ; Rao SS
Clin Vaccine Immunol; 2011 Nov; 18(11):1987-95. PubMed ID: 21918118
[TBL] [Abstract][Full Text] [Related]
45. Experimental dual infection of pigs with an H1N1 swine influenza virus (A/Sw/Hok/2/81) and Mycoplasma hyopneumoniae.
Yazawa S; Okada M; Ono M; Fujii S; Okuda Y; Shibata I; Kida H
Vet Microbiol; 2004 Mar; 98(3-4):221-8. PubMed ID: 15036530
[TBL] [Abstract][Full Text] [Related]
46. Immune efficacy of an adenoviral vector-based swine influenza vaccine against antigenically distinct H1N1 strains in mice.
Wu Y; Yang D; Xu B; Liang W; Sui J; Chen Y; Yang H; Chen H; Wei P; Qiao C
Antiviral Res; 2017 Nov; 147():29-36. PubMed ID: 28941982
[TBL] [Abstract][Full Text] [Related]
47. Seasonal FluMist vaccination induces cross-reactive T cell immunity against H1N1 (2009) influenza and secondary bacterial infections.
Sun K; Ye J; Perez DR; Metzger DW
J Immunol; 2011 Jan; 186(2):987-93. PubMed ID: 21160043
[TBL] [Abstract][Full Text] [Related]
48. Particle and subunit-based hemagglutinin vaccines provide protective efficacy against H1N1 influenza in pigs.
Hernandez LA; Miller CL; Vaughn EM
Vet Microbiol; 2016 Aug; 191():35-43. PubMed ID: 27374905
[TBL] [Abstract][Full Text] [Related]
49. Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice.
Kreijtz JH; Bodewes R; van Amerongen G; Kuiken T; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
Vaccine; 2007 Jan; 25(4):612-20. PubMed ID: 17005299
[TBL] [Abstract][Full Text] [Related]
50. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.
Bright RA; Carter DM; Daniluk S; Toapanta FR; Ahmad A; Gavrilov V; Massare M; Pushko P; Mytle N; Rowe T; Smith G; Ross TM
Vaccine; 2007 May; 25(19):3871-8. PubMed ID: 17337102
[TBL] [Abstract][Full Text] [Related]
51. Cross-protective immunity in mice induced by live-attenuated or inactivated vaccines against highly pathogenic influenza A (H5N1) viruses.
Lu X; Edwards LE; Desheva JA; Nguyen DC; Rekstin A; Stephenson I; Szretter K; Cox NJ; Rudenko LG; Klimov A; Katz JM
Vaccine; 2006 Nov; 24(44-46):6588-93. PubMed ID: 17030078
[TBL] [Abstract][Full Text] [Related]
52. Swine influenza virus: zoonotic potential and vaccination strategies for the control of avian and swine influenzas.
Thacker E; Janke B
J Infect Dis; 2008 Feb; 197 Suppl 1():S19-24. PubMed ID: 18269323
[TBL] [Abstract][Full Text] [Related]
53. Development of Eurasian H7N7/PR8 high growth reassortant virus for clinical evaluation as an inactivated pandemic influenza vaccine.
Jadhao SJ; Achenbach J; Swayne DE; Donis R; Cox N; Matsuoka Y
Vaccine; 2008 Mar; 26(14):1742-50. PubMed ID: 18336962
[TBL] [Abstract][Full Text] [Related]
54. Protection of ferrets from infection by swine-origin 2009 A (H1N1) influenza virus by the inactivated vaccine.
Shin JS; Do Hwang S; Kim HS; Cho SW; Seo SH
Viral Immunol; 2010 Aug; 23(4):395-402. PubMed ID: 20712484
[TBL] [Abstract][Full Text] [Related]
55. Seasonal influenza vaccine provides priming for A/H1N1 immunization.
Del Giudice G; Stittelaar KJ; van Amerongen G; Simon J; Osterhaus AD; Stöhr K; Rappuoli R
Sci Transl Med; 2009 Dec; 1(12):12re1. PubMed ID: 20371459
[TBL] [Abstract][Full Text] [Related]
56. Comparison of Adjuvanted-Whole Inactivated Virus and Live-Attenuated Virus Vaccines against Challenge with Contemporary, Antigenically Distinct H3N2 Influenza A Viruses.
Abente EJ; Rajao DS; Santos J; Kaplan BS; Nicholson TL; Brockmeier SL; Gauger PC; Perez DR; Vincent AL
J Virol; 2018 Nov; 92(22):. PubMed ID: 30185589
[TBL] [Abstract][Full Text] [Related]
57. Comparison of humoral and cellular immune responses to inactivated swine influenza virus vaccine in weaned pigs.
Platt R; Vincent AL; Gauger PC; Loving CL; Zanella EL; Lager KM; Kehrli ME; Kimura K; Roth JA
Vet Immunol Immunopathol; 2011 Aug; 142(3-4):252-7. PubMed ID: 21664701
[TBL] [Abstract][Full Text] [Related]
58. Evidence of a cross-protective immune response to influenza A in the cotton rat model.
Straight TM; Ottolini MG; Prince GA; Eichelberger MC
Vaccine; 2006 Sep; 24(37-39):6264-71. PubMed ID: 16860444
[TBL] [Abstract][Full Text] [Related]
59. Vaccine-mediated protection of pigs against infection with pandemic H1N1 2009 swine influenza A virus requires a close antigenic match between the vaccine antigen and challenge virus.
Everett HE; Aramouni M; Coward V; Ramsay A; Kelly M; Morgan S; Tchilian E; Canini L; Woolhouse MEJ; Gilbert S; Charleston B; Brown IH; Brookes SM
Vaccine; 2019 Apr; 37(17):2288-2293. PubMed ID: 30914224
[TBL] [Abstract][Full Text] [Related]
60. Mucosal vaccination against influenza: protection of pigs immunized with inactivated virus and ether-split vaccine.
Lim YK; Takada A; Tanizaki T; Ozaki H; Okazaki K; Kida H
Jpn J Vet Res; 2001 Feb; 48(4):197-203. PubMed ID: 11276584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
